Ocular hypotensive effect of topical ketanserin in timolol users

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 235, Issue 3, 1997, Pages 130-135

  Mastropasqua, Leonardo ^a,b   Ciancaglini, Marco ^b   Carpineto, Paolo ^b   Costagliola, Ciro ^c  

^a Institute of Ophthalmology ^*  (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; KETANSERIN; PHOSPHATIDYLINOSITIDE; SEROTONIN 1C RECEPTOR; SEROTONIN 2 RECEPTOR; TIMOLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LACRIMATION; MALE; OPEN ANGLE GLAUCOMA; ORAL DRUG ADMINISTRATION; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PUPIL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOCULAR PRESSURE; KETANSERIN; MALE; MIDDLE AGED; RETREATMENT; SEROTONIN ANTAGONISTS; TIMOLOL;

EID: 0030930998     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00941719     Document Type: Article

References (35)

1. Cazzola M, D'Amato G, Lobefalo G, Guillaro B, Sepe S, Assogna G (1987) Ketanserin, a new blocking agent of serotonin S2 receptors: respiratory functional effects in chronic obstruction of the airways. Chest 92: 863-867
2. Chang Fw, Burke JA, Potter DE (1985) Mechanism of the ocular hypotensive action of ketanserin. J Ocul Pharmacol 1: 137-147
3. Conway JL, Lewis RA (1980) Ocular hypotensive action of ketanserin. Invest Ophthalmol Vis Sci 30 [Suppl]: 24
4. Costagliola C, Scibelli G, Fasano ML, Ferrara LA and Mastropasqua L (1991) Effect on oral ketanserin administration on intraocular pressure in glaucomatous patients. Exp Eye Res 52: 507-510
5. Costagliola C, Ferrara LA, Fasano L, Iuliano G, Menzione M, Scibelli G, Mastropasqua L (1993) Ketanserin as an ocular hypotensive agent. Glaucoma 15: 55-59
6. Costagliola C, Iuliano G, Rinaldi M, Russo V, Scibelli G, Mastropasqua L (1993) Effect of topical ketanserin administration on intraocular pressure. Br J Ophthalmol 77: 344-348
7. Cyrlin MN, Thomas IV, Epstein DL (1982) Additive effect of epinephrine to timolol in primary open angle glaucoma. Arch Ophthalmol 100: 414-418
8. Dermailly P, Lehner M, Etienne R, Trepsat C, Hout J, Raynaud G (1979) Rèsultant d'une ètude à mòyen terme en double aveugle comparant le malèate de timolol ou l'èpinèphrine sur 120 patients parteur d'un glaucome chronique à angle ouvert. J Fr Ophthalmol 12: 727-735
9. Frazer A, Maayani S, Wolfe BB (1990) Subtypes of receptors for serotonin. Annu Rev Pharmacol Toxicol 30: 307-348
10. Greenidge KC, Spaeth GL, Fiol-Silva Z (1983) Effect of argon laser trabeculoplasty on the glaucomatous diurnal curve. Ophthalmology 90: 800-809
11. Hodapp E (1985) Computerized perimetry in glaucoma. In: Spaeth GL (ed) Computerized visual field. Slack, Thorofare, NJ, pp 197-238
12. Jones LJ (1966) The lacrimal system and its treatment. Am J Ophthalmol 62: 47-60
13. Karnezis TA, Murphy MB, Weber RR, Nelson KS, Tripathi BJ, Tripathi RC (1988) Effects of selective dopamine-1-receptor activation on intraocular pressure in man. Exp Eye Res 47: 689-698
14. Kass MA (1996) Standardizing the measurement of intraocular pressure for clinical research. Ophthalmology 103: 183-185
15. Krootila K, Palkama A, Uusitalo H (1987) Effect of serotonin and its antagonist (ketanserin) on intraocular pressure in rabbits. J Ocular Pharmacol 3: 279-290
16. Kurowski M (1985) Bioavailability and pharmacokinetics of ketanserin in elderly subjects. Eur J Clin Pharmacol 28: 411-417
17. Leier CV, Baker ND, Weber PA (1986) Cardiovascular effects of ophthalmic timolol. Ann Intern Med 104: 197-199
18. Marwood JF, Stokes GS (1984) Serotonin (5-HT) and its antagonists: involvement in the cardiovascular system. Clin Exp Pharmacol Physiol 11: 439-456
19. MacMahon CD, Shaffer RM, Hoskins HD, Hetherington J (1979) Adverse effects experienced by patients taking timolol. Am J Ophthalmol 88: 736-741
20. Osborne NN (1980) In vitro experiments on the metabolism uptake and release of 5-hydroxytryptamine in bovine retina. Brain Res 184: 283-291
21. Osborne NN, Tobin AB (1987) Serotonin accumulating cells in the irisciliary body and cornea of various species. Exp Eye Res 44: 731-746
22. Osborne NN, Meyer-Bothling U, Barnett NE (1994) Serotonin receptors in the eye. In: Anderson DR, Drance SM (eds) Encounters in glaucoma research. 1. receptor biology and glaucoma. Fogliazza, Abbiategrasso, Italy, pp 331-360
23. Palkama A, Lehtosalo J, Uusitalo H (1984) 5-Hydroxytryptamine receptors in the cornea and ciliary processes of the rabbit and human eyes. Ophthalmic Res 16: 207-208
24. Peroutka SJ (1990) 5-Hydroytryptamine receptor subtypes. Pharmacol Toxicol 67: 373-383
25. Rolando M (1984) Semeiotica della patologia del film lacrimale. In: Calabria G, Rolando M (eds) Fisiopatologia del film lacrimale. Soc Ophthalmol Ital, Rome, pp 97-132
26. Riemann IW, Frolich JC (1983) Mechanism of antihypertensive action of ketanserin in man. Br Med J 287: 381-383
27. Schirmer O (1903) Studien zur Physiologie und Pathologie der Tränenabsonderung und Tränenabfuhr. Graefes Arch F Ophthalmol 56: 197-291
28. Setten GV van, Stephen R, Tervo T, Salonen EM, Tarkkanen A, Vaheri A (1990) Effects of the Schirmer test on the fibrinolytic system in the tear fluid. Exp Eye Res 50: 135-141
29. Suda K, Furushima M, Kihara K (1961) Influence of antiglaucomatous surgery on the diurnal variation of the ocular tension in simple glaucoma. Acta Soc Ophthalmol Jpn 65: 1711-1719
30. Symoens J, Janssens M (1986) Ketanserin: a novel cardiovascular drug. Drug Dev Res 8: 159-172
31. Tobin AB, Unger W, Osborne NN (1988) Evidence for the presence of serotonergic neurones and receptors in the iris-ciliary body complex of the rabbit. J Neurosci 8: 3713-3721
32. Uusitalo H, Lehtosalo J, Laakso J, Harkonen M, Palkama A (1982) Immunocytochemical and biochemical evidence for 5-hydroxytryptamine containing nerves in the anterior part of the eye. Exp Eye Res 35: 671-675
33. Weinreb RN, Caldwell DR, Goode SM, Horwitz BL, Laibovitz R, Shrader E, Stewart RH, Williams T (1990) A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solution. Am J Ophthalmol 110: 189-192
34. Worthen DM (1976) Effect of pilocarpine drops on the diurnal intraocular pressure variation in patients with glaucoma. Invest Ophthalmol 15: 784-790
35. Yablonski ME, Zimmermam T, Walman S, Becker B (1987) A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res 44: 135-142